The warrants issued in the March 2024 Public Offering and 2025 November 2025 Public Offering are classified as liabilities in accordance with ASC 815, since these warrants met the definition of a derivative instrument and did not qualify for equity classification. These warrant agreements include a fundamental transaction clause whereby, in the event that another person or entity becomes the beneficial owner of 50% of the outstanding shares of the Company’s common stock, and if other conditions are met, the Company may be required to purchase the warrants from the holders by paying cash in an amount equal to the Black-Scholes value of the remaining unexercised portion of the warrants on the date of

such fundamental transaction. This liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire, and any change in fair value is recognized in the Company’s condensed statements of operations.

The fair value adjustment of the March 2024 Public Offering for the three months ended March 31, 2026 was $1.1 million using the Black-Scholes option-pricing model. As of March 31, 2026 all of the 2,500,000 warrants are outstanding. The Company estimated the fair value of the warrant liability using the following assumptions as of March 31, 2026:


Estimated dividend yield	—		%
Weighted-average expected stock price volatility	77.80		%
Weighted-average risk-free interest rate	3.81		%
Expected term (in years)	2.92
Weighted-average fair value per option	$	1.18

The fair value adjustment of the November 2025 Public Offering for the three months ended March 31, 2026 was $6.0 million using the Black-Scholes option-pricing model. As of March 31, 2026, all of the 6,107,500 warrants are outstanding. The Company estimated the fair value of the warrant liability using the following assumptions as of March 31, 2026:


Estimated dividend yield	—		%
Weighted-average expected stock price volatility	80.07		%
Weighted-average risk-free interest rate	3.90		%
Expected term (in years)	4.61
Weighted-average fair value per option	$	3.25


Balance at December 31, 2025	$	15,695
Issuance of warrants	—
Change in fair value of warrant liability	7,107
Balance at March 31, 2026	$	22,802